After a decade of genome-wide association studies (GWASs), fundamental questions in 3 human genetics are still unanswered, such as the extent of pleiotropy across the genome, the 4 nature of trait-associated genetic variants and the disparate genetic architecture across human 5 traits. The current availability of hundreds of GWAS results provide the unique opportunity 6 to gain insight into these questions. In this study, we harmonized and systematically analysed 7 4,155 publicly available GWASs. For a subset of well-powered GWAS on 558 unique traits, 8
Since the first genome-wide association study (GWAS) on macular degeneration in 2005   1   ,  18 over 3,000 GWASs have been published, for more than 1,000 traits, reporting on over tens of 19 thousands of significantly associated genetic variants 2 . Results from GWASs have increased 20 our insight into the genetic architectures of investigated traits, and for some traits, GWAS 21 results have led to further insight into disease mechanisms 3,4 , such as autophagy for Crohn's 22 disease 5 , immunodeficiency for Rheumatoid arthritis 6 and transcriptome regulation through 23 FOXA2 in the pancreatic islet and liver for Type 2 diabetes 7 . The emerging picture after over 24 a decade of GWASs is that the majority of studied traits are highly polygenic and thus 25 influenced by many genetic variants each of small effect 4, 8 , with disparate genetic 26 architectures across traits 9 . Fundamental questions, such as whether all genetic variants or all 27 genes in the human genome are associated with at least one trait, with many or even all traits, 28 and whether the polygenic effects for specific traits are functionally clustered or whether they 29 are randomly spread across the genome, are however still unanswered 4, 10, 11 . Answers to these 30 questions would greatly enhance our understanding of how genetic variation leads to trait 31 variation and trait correlation. Whereas GWAS primarily aims to discover genetic variants 32 associated with specific traits, the current availability of a vast amount of GWAS results can 33 be used to investigate some of these fundamental questions. 34
To this end, we compiled a catalogue of 4,155 GWAS results across 2,965 unique traits from 35 295 studies, including publicly available GWASs and new results for 600 traits from the UK 36 Biobank (http://atlas.ctglab.nl). These GWAS results were used in the current study to 37 achieve the following aims; i) charting the extent of pleiotropy at trait-associated locus, gene, 38 SNP and gene-set levels, ii) characterizing the nature of trait-associated variants (i.e. the 39 distribution of effect size, minor allele frequency and biological functionality of trait-40 associated or credible SNPs), and iii) understanding the nature of the genetic architecture 41 colocalized loci (Supplementary Table 6 ). Therefore, physical overlap of trait-associated 117 loci does not necessary mean that the same causal SNPs are involved in the traits associated 118 with such a grouped locus. Examination of pleiotropy at the gene or SNP level will provide 119 further insight into the nature of the pleiotropy observed at the locus level. 120
121

Pleiotropic genes 122
We next investigated the extent of pleiotropy at the gene level. For this, we conducted a 123 gene-based analysis on 17,444 protein-coding genes using MAGMA for each trait 16 124 (Methods). Of the 558 traits, 516 yielded at least one significantly associated gene and 125 11,443 (65.6%) genes were significantly associated to at least one trait (Supplementary 126 Table 7 ). Of these, 81.0% were associated with more than one trait and 66.9% were 127 associated with traits from multiple domains ( Table 1 and Extended Data Fig. 5a, b) . We 128 found that genes associated with at least one trait are significantly longer than genes that are 129 not associated with any of the 558 tested traits (p=2.1e-194, p=8.7e-12 and p=3.8e-29 for 130 multi-domain, domain-specific and trait-specific genes, respectively; Fig. 1b and 131
Supplementary Table 8).
As the MAGMA algorithm is insensitive to bias caused by gene-132 length, these findings are unlikely to be due to larger genes having an increased statistical 133 probability to be significantly associated (Supplementary Information 4, Extended Data 134 Table 9 ). The multi-domain genes showed a significantly higher 135 probability of being intolerant to loss of function mutations (pLI score) 19 compared to trait-136 /domain-specific and non-associated genes (p=1.2e-79, p=4.8e-22 and p=2.8e-19, 137 respectively; Fig. 1c and Supplementary Table 10), suggesting that more pleiotropic genes 138 are on average less tolerant to loss of function variants. The most pleiotropic genes are 139 located in the MHC region, yet a region on chromosome 3 also spanned multiple genes with 140 trait and 32.4% were associated with more than one domain (Table 1 and Extended Data 166
Fig. 6d). 167
These pleiotropic SNPs spread broadly across the genome but were not evenly distributed, 168
i.e. chromosome 1, 11, 12, 15, 17, 20 and 22 showed relative enrichment of pleiotropic SNPs 169
(Supplementary Information 5 and Supplementary Table 13) . Of all associated SNPs, the 170 most pleiotropic SNP, located in the MHC region (rs707939; an intronic SNP of MSH5) was 171 associated with 48 traits from 13 domains. There were 45 SNPs associated with 12 trait 172 domains, of which 35 were located on chromosome 3, 49.8Mb-50.1Mb overlapping with 5 173 protein coding genes, TRAIP, CAMKV, MST1R, MON1A and RBM6. These SNPs include two 174 exonic SNPs, rs2681781 (synonymous on CAMKV) and rs2230590 (nonsynonymous on 175
MST1R; Supplementary Table 12). 176
To investigate whether SNPs with a higher level of pleiotropy have different functional 177 annotations than less pleiotropic SNPs, we investigated how functional consequence and 178 tissue specificity in terms of expression quantitative trait loci (eQTLs) were represented 179 across different levels of SNP pleiotropy (Methods). We found that the proportion of intronic 180 and exonic SNPs increased as a function of the level of pleiotropy (p=2.2e-3 and p=1.7e-2, 181 respectively); the proportion of exonic SNPs increased from less than 1% to over 5%, and the 182 proportion of intronic SNPs increased from less than 40% to over 50% ( Fig. 1e and  183 Supplementary Table 14) with increasing levels of pleiotropy. The proportion of SNPs 184 within flanking regions such as 5' and 3' untranslated regions (UTR) also increased with the 185 number of associated domains. At the same time, we observed a steep decrease of the 186 proportion of intergenic SNPs with increasing level of SNP pleiotropy (p=8.1e-4; Fig. 1e and 187 Supplementary Table 14) . Based on active eQTLs, the proportion of SNPs being eQTLs in 188 a greater number of tissue types (>24 tissue types out of 48) increased along with the number 189 of associated domains (p=8.4e-3 and p=1.1e-2 for eQTLs in between 25 and 36 tissues, and 190 between 37 and 48 tissues, respectively) while SNPs in genes expressed in a single or less 191 than half of available tissue types showed decreasing proportion ( Fig. 1f and Supplementary 192 The most pleiotropic gene-set was 'Regulation of transcription from RNA polymerase II 202 promoter' (GO biological process) associated with 61 traits from 9 domains, followed by 7 203 other gene-sets associated with 7 domains, of which 5 of them were also involved in 204 regulation of transcription (Supplementary Table 16 ). We observed that the number of 205 genes in a gene-set was significantly larger for highly pleiotropic gene-sets (associated with 206 more than one domain) compared to other gene-sets (domain-specific, trait-specific and non-207 associated; p=4.1e-12, p=1.6e-13 and p=1.2e-29, respectively; Extended Data Fig. 7a , and 208 Supplementary Table 17) . Since GO terms (55.6% of tested gene-sets) have a hierarchical 209 structure, the larger gene-sets are more likely to be located at the top of the hierarchy, 210 representing more general functional categories. 211
In contrast to the pleiotropy at gene level where 80.9% genes were associated with more than 212 one trait, we only found 54.8% of the associated gene-sets to be pleiotropic (Table 1) . We 213 observed that the proportion of pleiotropic genes per gene-set is not uniformly distributed, 214 and pleiotropic genes tend to cluster into a subset of gene-sets, explaining the decreased 215 proportion of pleiotropic gene-sets compared to pleiotropic genes (Extended Data Fig. 7b,  216 c). At the same time, the higher proportion of trait-specific gene-sets (45.2%) compared to 217 trait-specific genes (19.2%) suggests that, given current definitions of gene-sets, the 218 combination of associated genes is rather unique to a trait and focusing on gene-sets to gain 219 insight into trait-specific biological mechanisms may be more informative than focusing on 220 single genes (Supplementary Information 6) . 221
222
Genetic correlations across traits 223
Above we showed that of all trait-associated loci, genes and SNPs that are associated with at 224 least one trait, 90.0%, 66.9% and 32.6% are associated with more than one domain, 225
respectively. Such wide-spread pleiotropy indices non-zero genetic correlations between 226 traits. To test whether genetic correlations are evenly present across traits or cluster into trait 227 domains, we computed pairwise genetic correlations (rg) across 558 traits using LDSC 17 . 228
We calculated the proportion of trait pairs with an rg that is significantly different from zero 229 across all 558 traits, within domains and between domains. Out of 155,403 possible pairs 230 across 558 traits, 24,106 pairs (15.5%) showed significant genetic correlations after 231
Bonferroni correction (p<0.05/155,403=3.2e-7) with an average |rg| of 0.38. 232
In principle, if the trait domains contain traits that are biologically related, we would expect 233 that traits within the same domain have stronger genetic correlations than traits across 234 domains. The proportion of pairs with a significant genetic correlation within a domain was 235 especially high in cognitive, 'ear, nose, throat', metabolic and respiratory domains, and for 236 most of domains, average |rg| across significant trait pairs was higher than 0.38 (across all 237 traits). Note that the proportion of trait pairs with significant rg may be biased by sample size 238 and h 2 SNP of traits within a domain; across 558 traits, the worst case scenarios with the 239 minimum observed h 2 SNP (0.0045 with sample size 385,289) or the minimum sample size 240 (51,750 with h 2 SNP =0.0704) required rg to be above 0.39 or 0.18, respectively, to gain a 241 power of 0.8 (Methods). Within domain, the majority of significant genetic correlations was 242 positive and the average |rg| was above 0.5 in most of the domains (Fig. 2a and  243 Supplementary Table 18 ). Between domains, the proportion of pairs with significant genetic 244 correlations was generally lower than within domains, and most of the domain pairs showed 245 average |rg|<0.4 (Fig. 2b and Supplementary Table 19 ). Some trait domains showed a 246 predominance of negative genetic correlations with other domains, i.e. activity, cognitive, 247 reproduction and social interaction domains. We further clustered traits based on genetic 248 correlations, which resulted in the majority of clusters contained traits from multiple domains 249 (Methods, Supplementary Information 7 and Extended Data Fig. 8 ). These results 250 suggest that although |rg| is higher within domain than across domains, the trait domains do 251 not necessary reflect genetic similarity across traits. 252
253
The nature of trait-associated variants 254
We now address the question whether trait-associated variants differ from genetic variants 255 that are not associated with any trait. For this purpose, we extracted all lead SNPs from each 256 of the 558 GWASs. Lead SNPs were defined per trait at the standard threshold for genome-257 wide significance (p<5e-8) and using an r 2 of 0.1 to obtain near-independent lead SNPs, 258 based on the population-relevant reference panel (see Methods). Lead SNPs with minor 259 allele count (MAC) £100 (based on MAF and sample size of the SNP) were excluded due to 260 lower statistical power and a high false positive rate of effects of SNPs with extremely small 261 SNPs with a MAF above 0.01 was nearly uniform (Fig. 3a) . 269
To gain insight into the distribution of effect sizes across lead SNPs, we calculated the 270 standardized effect size (β) from Z-statistics as a function of MAF and sample size 21 , and 271 inspected the distribution of the squared standardized effect sizes (β 2 ) for lead SNPs across 272 all traits (Methods). β ranged between 0.01 and 1.70, and β 2 is proportional to the variance 273 explained. The median β 2 of the lead SNPs across all traits was 5.7e-4 (4.9e-4 and 6.0e-2 for 274 lead SNPs with MAF³0.01 and <0.01, respectively), and 94.6% of lead SNPs had a β 2 below 275 0.05 (Fig. 3b) . Thus, the vast majority of lead SNPs thus explained less than 0.05% of the 276 trait variance. We observed a relationship between MAF and standardized effect size, with 277 rare variants (MAF<0.01) showing larger effect sizes (Fig. 3c) . This is in line with the notion 278 that rare variants are more likely to have large effects compared to common variants, as they 279 are less likely to be under strong selective pressure 22 . However, we also note that statistical 280 power for detecting the rare variants is un-stable 23 . Given that the proportion of rare lead 281
SNPs is larger than the proportions in other MAF bins, it is possible that the distribution of 282 the effect sizes has longer tails for SNPs with MAF<0.01. For most of the traits, a similar 283 relationship between MAF and standardized effect size was observed (Extended Data 
Characterization of trait-associated loci and lead SNPs 290
Here we sought to characterise differences in the distribution of functional annotations when 291 comparing SNPs within trait-associated loci to all SNPs in the genome, and comparing lead 292
SNPs to SNPs in the trait-association loci (Methods). We first compared SNPs in the trait-293 associated loci against the entire genome. The strongest enrichment of SNPs in trait 294 associated loci was seen in flanking regions (upstream, downstream, 5' and 3' UTR) with 295 average fold enrichment (E) 1.31 ( Fig. 3d and each variant in the loci (effect sizes and LD structure) to assign posterior probability of each 318 specific model at particular locus, which are then used to infer the posterior probabilities of 319 each SNP being included in the model (posterior inclusion probability, PIP) and ascertain the 320 minimum set of SNPs required to capture the likely causal variant. We performed fine-321 mapping using FINEMAP software 25 for each trait-associated locus, setting the maximum 322 number of SNPs in the causal configuration (k) to 10 and using randomly selected i.e. significant enrichment of SNPs in intronic and flanking regions but the fold enrichment 331 was much smaller (Fig. 3d and Table 2 ). This is mainly because the fine-mapped regions are 332 often larger than the trait-associated loci by taking 50kb around the top SNPs of the trait-333 associated loci. In contrast, fold enrichment of exonic SNPs was slightly higher than trait-334 associated loci ( Table 2 ). As we observed higher gene-density around the trait-associated 335 loci, expanding the loci resulted in larger proportion of exonic regions. Both active chromatin 336 state and eQTLs were significantly enriched, however, fold enrichment of eQTLs was 337 notably less than trait-associated loci (Fig. 3e-f 
Polygenicity and discoverability of complex traits 383
The general observation from GWASs is that with increasing sample size, detected signals 384 become not only more reliable but also more numerous, as with increasing power, smaller 385 SNP effects may be detected. The total number of associated SNPs, the amount of variance 386 they collectively represent, the distribution of effect sizes across the associated SNPs and 387 how many additional individuals are expected to be needed for the detection of a fixed 388 number of novel SNPs, are indications of the polygenicity of a trait. Such polygenicity may 389 vary across traits, and can be informative for designing SNP-discovery studies. 390
To obtain an indication of trait-polygenicity, we applied the Causal Mixture Model for 391 GWAS summary statistics (MiXeR) 28 to estimate π (fraction of independent causal SNPs, 392 polygenicity) and σβ 2 (variance of effect sizes of the causal SNPs, discoverability; see 393 Supplementary Table 23 ). We observed, as expected, a negative 399 relationship between polygenicity and discoverability (r=-0.89 and p=4.93e-70), confirming 400 that highly polygenic traits tend to have less causal SNPs with larger effect sizes (Fig. 4b) . 401
Methods
The majority of traits (i.e. 116 traits) showed high polygenicity with π>1e-3 (more than 0.1% 402 of all SNPs are causal). The highest polygenicity was observed in Major depressive disorder 403 with 0.6% of SNPs being causal, while some traits, such as fasting glucose and serum urate 404 level showed relatively low polygenicity ( Fig. 4b and Supplementary Table 23 ). The traits 405 with polygenicity >0.1% showed, on average, 8 times less discoverability compared to other 406 traits with <0.1% of causal SNPs. The GWAS discoveries for traits with lower polygenicity 407 and high discoverability will saturate with a lower sample size compared to the traits with 408 higher polygenicity. Indeed, the estimated sample size, which is required to explain 90% of 409 SNP heritability by genome-wide significant SNPs, is positively correlated with polygenicity 410 (r=0.84 and p=6.30e-54), and extremely polygenic traits require tens of millions of subjects 411 to identify 90% of causal SNPs at a genome-wide significant level (Fig. 4c) . 412
413
Discussion 414
The availability of hundreds of GWAS results provides the unique opportunity to gain insight 415 into currently understudied questions regarding the genetic architecture of human traits. To 416 facilitate such insight, we compiled a catalogue of 4,155 GWASs which can be queried 417 online (http://atlas.ctglab.nl). We selected 558 well-powered GWASs to answer fundamental 418 questions concerning the extent of pleiotropy of loci, genes, SNPs and gene-sets, 419 characteristics of trait-associated variants and the polygenicity of traits. 420
We found that the total summed length of trait-associated loci for the 558 analysed traits 421 covered more than half (60.1%) of the genome. 90% of the grouped loci contained 422 associations with multiple traits across multiple trait domains. High locus pleiotropy can 423 occur in two scenarios; i) when the same gene in a locus is associated with multiple traits or 424
ii) when different genes or SNPs in the same locus are associated with multiple traits but due 425 to LD the same locus is indicated. Our results showed that the proportion of pleiotropic 426 associations dropped from 90% at the locus level to 63% at the gene level, and to 31% at the 427 SNP level. These results show that although locus pleiotropy is widespread, pleiotropy at the 428 level of genes and SNPs is much less abundant. This suggests that a gene can be involved in 429 two distinct traits but how that gene is affected by the causal SNPs might differ. For instance, 430 the function of the gene can be disrupted through a coding SNP for one trait, but expression 431 of the same gene can be affected through a regulatory SNP for another trait. 432
Genes and SNPs that had a higher level of pleiotropy, were less tissue specific in terms of 433 gene expression and active eQTLs. This suggests that SNPs and genes associated with 434 multiple trait domains are more likely to be involved in general biological functions. Indeed, 435 the top highly pleiotropic gene-sets were mostly involved in regulation of transcription which 436 is an essential biological mechanism for any kind of cell to be functioning. Highly pleiotropic 437 genes, therefore, can explain general vulnerability to a wide variety of traits, yet they may be 438 less informative when the aim is to understand the causes of a specific trait. Although a large 439 proportion of trait-associated genes are pleiotropic, the majority of trait associated gene-sets 440
were trait-specific. Thus, the trait-specific combination of genes is highly informative, and 441 future studies aimed at improved annotation of gene-functions will be needed to understand 442 trait-specific gene association patterns. 443
It has been widely acknowledged that almost 90% of GWAS findings fall into non-coding 444 publication was available and sample size for a specific trait was explicitly mentioned in the 477 original study. We excluded non-GWAS studies (e.g. PAGE (Prenatal Assessment of 478
Genomes and Exomes) studies) and GWASs with immune-chip, whole exome sequencing 479 and replication cohorts (exact reasons of exclusion for each dataset is available in 480 Supplementary Table 24) . 481
Together this resulted in a total of 3,555 GWAS summary statistics. The complete list and 482 detailed information for each GWAS with summary statistics is available in Supplementary 483 dichotomized each code to dummy binary phenotypes (cases for 1 and controls for 0) and 507 included subjects with phenotype code -7 for "None of the above" as controls. Again, 508 subjects with phenotype codes -1 for "Do not know" or -3 for "Prefer to not answer" were 509 excluded. For example, field 670 based on UKB Data-Coding 100286 is coded from 1 to 5 510 and dichotomization results in five phenotypes such as 1 vs all others, 2 vs all others and so 511 on. Detailed definitions of multi-coded phenotypes are described in Supplementary Table 2 . 512
After phenotyping, we selected phenotypes that had at least 50,000 European subjects. For 513 binary traits, we further restricted to traits with at least 10,000 cases and controls. This 514 resulted in a total of 600 traits (260 quantitative and 340 binary traits). Note that the final 515 total sample size encoded in the atlas database (http://atlas.ctglab.nl) might be less than 516 50,000 due to lack of genotype data or missing values in covariates. 517 The complete list of traits from UK biobank release 2 analysed in this study is available in 522 Curated summary statistics were pre-processed to standardize the format. SNPs with p£0 or 526 >1, or non-numeric values such as "NA" were excluded. For summary statistics with non-527 hg19 genome coordinates, liftOver software was used to align to hg19. When only rsID was 528 available in the summary statistics file without chromosome and position, genome 529 coordinates were extracted from dbSNP 146. When rsID was missing, it was assigned based 530 on dbSNP 146. When only the effect allele was reported, the other allele was extracted from 531 dbSNP 146. 532 533
Supplementary
Definition of lead SNPs and trait-associated loci 534
For each GWAS, we defined lead SNPs and genomic trait-associated loci as described before 535 30 . First, we defined independent significant SNPs with p<5e-8 and independent at r 2 <0.6, 536 and defined LD blocks for each of independent significant SNPs based on SNPs with p<0.05. 537
Of these SNPs, we further defined lead SNPs that are independent at r 2 <0.1. We finally 538 defined genomic trait-associated loci by merging LD blocks closer than 250kb. Each trait-539 associated locus was then represented by the top SNP (with the minimum P-value) and its 540 genomic region was defined by the minimum and maximum position of SNPs which are in 541 LD (r 2 ³0.6) with one of the independent significant SNPs within the (merged) locus. We 542 used 1000 genome phase 3 (1000G) 31 as a reference panel to compute LD for most of the 543 GWASs in the database. For each GWAS, the matched population (from AFR, AMR, EAS, 544 EUR, SAS) was used as the reference based on the information obtained from the original 545 study. For trans-ethnic GWASs, the population with the largest total sample size was used. 546
When the GWAS was based on the UKB release 1 cohort (UKB1), we used 10,000 randomly 547 sampled unrelated White British subjects from UKB1 as reference. For other GWASs 548 performed in this study or GWASs based on the UKB2, 10,000 randomly selected unrelated 549 EUR subjects were used as a reference. Non-bi-allelic SNPs were excluded from any 550
analyses. 551
The reference panel used for each GWAS is provided in the column "Population" of 552 Supplementary Table 3 . For trans-ethnic GWASs, the first population was used as 553 reference, e.g. EUR+EAS+SAS means EUR had the largest sample. GWASs based on the 554 UKB cohort was encoded either "UKB1 (EUR)" for UKB release 1 or "UKB2 (EUR)" for 555 UKB release 2. 556 557
MAGMA gene and gene-set analysis 558
We performed MAGMA v1.06 16 gene and gene-set analyses for every GWAS in the 559 database. For gene-analysis, 20,260 protein-coding genes were obtained using the R package 560
BioMart (Ensembl build v92 GCRh37). SNPs were assigned to genes with 1kb window at 561 both sides. The reference panel of corresponding populations used for each GWAS was based 562 on either 1000G, UKB1 or UKB2 as described in the previous section. The gene-set analysis 563 was performed with default parameters (snp-wise mean model). Gene-set analysis was 564 performed for 4,737 curated gene-sets (C2) and 5,917 GO terms (C5; 4,436 biological 565 processes, 580 cellular components and 901 molecular functions) from MsigDB v6.1 566 (http://software.broadinstitute.org/gsea/msigdb, last accessed 20 Apr 2018) 32 . 567 568 SNP heritability and genetic correlation with LD score regression 569
We performed LD score regression (LDSC) 17 for each GWAS to obtain SNP heritability and 570 pairwise genetic correlations. Pre-calculated LD scores for 1000G EUR and EAS populations 571 were obtained from https://data.broadinstitute.org/alkesgroup/LDSCORE/ (last accessed 26 572
Nov 2016) and LD score regression was only performed for GWASs with either an EUR or 573 EAS population and when the number of SNPs in the summary statistics file was > 450,000. 574 LDSR was performed only for HapMap3 SNPs excluding the MHC region (25Mb-34Mb). 575
When the signed effect size or odds ratio was not available in the summary statistics file, "--576 a1-inc" flag was used. As recommended previously 33 , we excluded SNPs with chi-square 577 >80. For binary traits, the population prevalence was curated from the literature (only for 578 diseases whose prevalence was available, Supplementary Table 25) to compute SNP 579 heritability at the liability scale with "--samp-prep" and "--pop-prep" flags. For most of the 580 personality/activity (binary) traits from UKB2 cohort, we assumed that the sample prevalence 581 is equal to the population prevalence since the UK Biobank is a population cohort and not 582 designed to study a certain disease/traits. Likewise, when population prevalence was not 583 available, sample prevalence was used as population prevalence for all other binary traits. 584
Genetic correlations were computed for pair-wise GWASs with the following criteria as 585 suggested previously 33 : 586 There was one exception for height GWAS, where a meta-analysis by Yengo et al. 34 (ID 624 4044) has the larger sample size, however the meta-analysis was limited to ~2.4 million 625
HapMap 2 SNPs. Since over 10 million SNPs are included in most of the selected GWASs, 626 this smaller number of SNPs can bias our analyses. Therefore, the second largest GWAS 627 (UKB2 GWAS performed in this study, ID 3187) was used instead. This resulted in total of 628 558 GWASs, across 24 domains, which were subsequently used in the cross-phenotype 629 analyses in this study. These 558 GWASs are specified in Supplementary Table 3 . 630
631
Pleiotropic trait-associated loci 632
To define pleiotropic loci for the 558 traits (GWASs), we first extracted trait-associated loci 633 on autosomal chromosomes. We excluded any locus with a single SNP (no other SNPs have 634 r 2 >0.6) as these loci are more likely to be false positives. We then grouped physically 635 overlapping loci across 558 traits. In a group of loci, it is not required that all individual trait-636 associated loci are physically overlapping but merging them should result in a continuous 637 genomic region. For example, when trait-associated loci A and B physically overlap and trait-638 associated loci B and C also physically overlap, but A and C do not, these three trait-639 associated loci were grouped into a single group of loci (Extended Data Fig. 3) . Therefore, a 640 grouped locus could contain more than one independent locus from a single trait when gaps 641 between them were filled by loci from other traits. The grouped loci were further assigned to 642 three categories, i) multi-domain locus when a loci group contained traits from more than one 643 domain, ii) domain specific locus when a loci group contained more than one trait from the 644 same domain, and iii) trait specific locus when a locus did not overlap with any other loci. 645
We compared the distribution of gene density across four association categories of the loci; 646 multi-domain, domain specific and trait specific loci, and non-associated genomic regions. 647
To define non-associated genomic regions, we extracted the minimum and maximum 648 positions that were covered by 1000G, and the gap regions of grouped trait-associated loci 649
were defined as non-associated regions. The gene density was computed as a proportion of a 650 region that was overlapping with one of 20,260 protein-coding genes obtained from Ensembl 651 v92 GRCh37. We then performed pairwise Wilcoxon rank sum test (two sided). 652 653
Colocalization of trait-associated loci 654
To evaluate if physically overlapping trait-associated loci also share the same causal SNPs, 655 we performed colocalization using the coloc.abf (Approximate Bayes Factor colocalization 656 analysis) function of the coloc package in R 35 . Colocalization analysis was performed for all 657 possible pairs of physically overlapping trait-associated loci across 558 traits. When two loci 658 from different traits were physically overlapping but there were no SNPs that were present in 659 both GWAS summary statistics in that overlapping region, colocalization was not performed. 660
The inputs of the coloc.abf function are P-value, MAF and sample size for each SNP. When 661 MAF was not available in the original summary statistics, it was extracted from the matched 662 reference panel. For binary traits, sample prevalence was additionally provided based on total 663 cases and controls of the study. 664
The coloc.abf function assumes a single causal SNP for each trait and estimates the posterior 665 probability of the following 5 scenarios for each testing region; H0: neither trait has a genetic 666 association, H1: only trait 1 has a genetic association, H2: only trait 2 has a genetic 667 association, H3: both trait 1 and 2 are associated but with different causal SNPs and H4: both 668 trait 1 and 2 are associated with the same single causal SNP. In this study, as we pre-define 669 the trait-associated loci for each trait which already discard scenarios H0 to H2, we are only 670 interested whether H4 is most likely. We therefore defined, a pair of loci as colocalised when 671 the posterior probability of H4 is >0.9. We note that it is possible that genomic regions 672 outside of the pre-defined trait-associated loci can also colocalize with other traits. However, 673
we limited the analyses to the pre-defined trait-associated loci in this study, to be consistent 674 with the level of pleiotropy measured by physical overlap of the loci. 675
Within a grouped locus defined based on physical overlap (see above), we further grouped 676 loci based on a colocalization pattern. To do so, we considered colocalization pattern across 677 group of physically overlapping loci as a graph in which nodes represent trait-associated loci 678 and edges represent colocalization of the loci First, loci which did not colocalized with any 679 other loci were considered as independent loci. For the rest of the loci, we identified 680 connected components of the graph (Extended Data Fig. 3 
Pleiotropic genes 687
For gene level pleiotropy, we extracted MAGMA gene analysis results for the 558 traits 688 where 17,444 genes on autosomal chromosomes were tested in all GWASs. For each trait, 689 genes with p<2.87e-6 (0.05/17,444) were considered as significantly associated. We did not 690 correct the P-value for testing 558 traits since our purpose is not to identify genes associated 691 with one of the 558 traits but to evaluate the overlap of trait-associations (when GWAS was 692 performed for a single trait) across the 558 traits, and this applies to SNPs and gene-set level 693 pleiotropy. The trait associated genes were further categorized into three groups in a similar 694 way as for trait-associated loci, i.e. i) multi-domain genes that were significantly associated 695 with traits from more than one domain, ii) domain-specific genes that were significantly 696 associated with more than one trait from the same domain and iii) trait-specific genes that 697 were significantly associated with a single trait. 698
We compared gene length and pLI score across genes in three different association categories 699 and non-associated genes. Gene length was based on the start and end position of genes 700 extracted from the R package biomaRt and pLI score was obtained from To enable comparison of effect sizes across GWASs from different studies, we first 769 converted P-values into Z-statistics (two sided) and expressed the estimated effect size as a 770 function of MAF and sample size as described previously 21 using the following equations: 771
where p is MAF and n is the total sample size. We used the MAF of a corresponding 773
European reference panel (either 1000G, UKB1 or UKB2) as described in the previous 774 section "Definition of lead SNPs and genomic trait-associated loci". Since we were not 775 interested in the direction of effect, we used squared standardized effect sizes for analyses in 776 this study. 777 778
Fine-mapping of trait-associated loci 779
We defined the region to fine-map by taking 50kb around the top SNPs of the trait-associated 780 loci. When trait-associated loci were larger than the 50kb window, the largest boundary was 781 taken. Due to the complex LD structure, loci overlapping with the MHC region (chr6:25Mb-782 36Mb) were excluded. The fine-mapping was performed using the FINEMAP software 783 (http://www.christianbenner.com/#) with shotgun stochastic search algorithm 25 . Since the 784 coverage of true causal SNPs is affected by the sample size of the reference panel and 785
GWASs 38 , we used randomly selected unrelated 100k EUR individuals from UKB2 cohort 786 for all 558 GWASs. We limited the number of maximum causal SNPs (k) per locus to 10. 787
When the number of SNPs within a locus is relatively small (around 30 or less), the algorithm 788 can fail to converge. In that case, k was decreased by 1 until FINEMAP was successfully run. 789
Loci with less than 10 SNPs were excluded from the fine-mapping. 790 coordinates. Subsequently, consequence state was assigned for each SNP by taking the most 807 common state across 127 cell/tissue types. SNPs with consequence state£7 were defined as 808 active. eQTLs in 48 tissue types were obtained from GTEx v7 20 and we only used the 809 significant eQTLs at gene q-value<0.05. eQTLs were assigned to SNPs by matching 810 chromosome coordinate and alleles. 811
As we showed that trait-associated loci have higher gene density compared to non-associated 812 regions, and GWAS signals are known to be enriched in regulatory elements 40 , we first 813 identified background enrichment by comparing SNPs within trait-associated loci or fine-814 mapped regions with the entire genome. For this all known SNPs were extracted by 815 combining all SNPs in 1000G, UKB1 and UKB2 reference panels (~28 million SNPs in 816 total). SNPs within the trait-associated loci were defined as the ones with P-value<0.05 and 817 r 2 >0.6 with one of the independent significant SNPs as described above (see section 818 'Definition of lead SNPs and trait-associated loci'). Therefore, it does not necessary include 819 all SNPs physically located within the trait-associated loci. On the other hand, SNPs within 820 fine-mapped region include all SNPs physically located within 50kb window from the most 821 significant SNP of a locus. To characterize lead SNPs and credible SNPs given background 822 enrichments, we compared these SNPs against all SNPs within trait-associated loci or fine-823 mapped regions, respectively. 824
825
SNP heritability estimation with SumHer using LDAK model 826
We estimated SNP heritability of 558 traits using the SumHer function from the LDAK 827 is chi-squared statistics and n is sample size of the SNP) were excluded. 834
To obtain SNP heritability in a liability scale, we provided population prevalence and sample 835 prevalence with flags '--prevalance' and '--ascertainment' for binary traits. The same 836 population prevalence was used as described in the section of SNP heritability estimate with 837 Table 25 where π is the proportion of (independent) causal SNPs and σβ 2 is the variance of the effect 846 sizes of causal SNPs. Therefore, π and σβ 2 respectively represent polygenicity and 847 discoverability of the trait. We estimated both parameters for the 558 traits using MiXeR 848 software (https://github.com/precimed/mixer) 28 . As recommended in the original study, we 849 used 1000G EUR as a reference panel and restricted to HapMap 3 SNPs. SNPs with c 2 >80 850 and the MHC region (chr6:26Mb-34Mb) were excluded. To estimate the sample size required 851 to explain 90% of the additive genetic variance of a phenotype, we used an output of GWAS 852 power estimates calculated in the MiXeR software, which contains 51 data points of sample 853 size and the proportion of chip heritability explained 28 . We then estimated the sample size 854 required to reaches 90% by using the interp1 function from the pracma package in R. 855
LDSC (Supplementary
856
Data and materials availability 857
All publicly available GWAS summary statistics (original) files curated in this study are 858 accessible from the original links provided at http://atlas.ctglab.nl. GWAS summary statistics 859 for 600 traits from UK Biobank performed in this study are also provided at 860 http://atlas.ctglab.nl and an archived file will be made available upon publication from 861 E: fold enrichment (proportion of SNPs with a certain annotation divided by the proportion of SNPs with the same annotation in background). 978 a Only including the fine-mapped regions (for loci larger than 50kb windows from the top SNPs, the largest boundaries were taken).
b From 95% 979 credible set SNPs, only SNPs with posterior inclusion probability (PIP)>0.95 were selected. c P-value of Fisher's exact test (two-sided) against 980 the entire genome.
d P-value of Fisher's exact test (two-sided) against trait-associated loci. e P-value of Fisher's exact test (two-sided) against 981 50kb around the top SNPs. 982 
